BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34544507)

  • 1. Impact of smoking Behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study.
    van der Heijden HS; Schirmbeck F; Kempton MJ; van der Gaag M; Allott K; Nelson B; Ruhrmann S; de Haan L; Vermeulen JM;
    Eur Psychiatry; 2021 Sep; 64(1):e60. PubMed ID: 34544507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
    Hou CL; Xiang YT; Wang ZL; Everall I; Tang Y; Yang C; Xu MZ; Correll CU; Jia FJ
    Schizophr Res; 2016 Jul; 174(1-3):71-76. PubMed ID: 27197904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between tobacco use and symptomatology in individuals at ultra-high risk to develop a psychosis: A longitudinal study.
    van der Heijden HS; Schirmbeck F; McGuire P; Valmaggia LR; Kempton MJ; van der Gaag M; Nelson B; Riecher-Rössler A; Bressan R; Barrantes-Vidal N; Ruhrmann S; Sachs G; de Haan L; Vermeulen JM;
    Schizophr Res; 2021 Oct; 236():48-53. PubMed ID: 34390981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study.
    Vermeulen JM; Schirmbeck F; Blankers M; van Tricht M; Bruggeman R; van den Brink W; de Haan L;
    Am J Psychiatry; 2018 Nov; 175(11):1121-1128. PubMed ID: 30138044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?
    Becker HE; Nieman DH; Wiltink S; Dingemans PM; van de Fliert JR; Velthorst E; de Haan L; van Amelsvoort TA; Linszen DH
    Psychol Med; 2010 Oct; 40(10):1599-606. PubMed ID: 20132582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms.
    Anda L; Brønnick KK; Johannessen JO; Joa I; Kroken RA; Johnsen E; Rettenbacher M; Fathian F; Løberg EM
    Front Psychiatry; 2019; 10():695. PubMed ID: 31632305
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurocognition and social cognition in youth and young adults at ultra-high-risk for psychosis and bipolar disorder.
    Bora E; Eyuboglu MS; Cesim E; Demir M; Yalincetin B; Ermis C; Özbek Uzman S; Sut E; Demirlek C; Verim B; Baykara B; Akay A; İnal N; Akdede BB
    Schizophr Res; 2024 Apr; 266():58-65. PubMed ID: 38368706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome.
    Simon AE; Grädel M; Cattapan-Ludewig K; Gruber K; Ballinari P; Roth B; Umbricht D
    Schizophr Res; 2012 Dec; 142(1-3):108-15. PubMed ID: 23025995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interview and questionnaire assessment of cognitive impairment in subjects at ultra-high risk for psychosis: Associations with cognitive test performance, psychosocial functioning, and positive symptoms.
    Randers L; Fagerlund B; Jepsen JRM; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Psychiatry Res; 2020 Dec; 294():113498. PubMed ID: 33157481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine usage is associated with elevated processing speed, spatial working memory, and visual learning performance in youth at ultrahigh-risk for psychosis.
    Gupta T; Mittal VA
    Psychiatry Res; 2014 Dec; 220(1-2):687-90. PubMed ID: 25190344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis?
    Bora E; Murray RM
    Schizophr Bull; 2014 Jul; 40(4):744-55. PubMed ID: 23770934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial working memory ability in individuals at ultra high risk for psychosis.
    Goghari VM; Brett C; Tabraham P; Johns L; Valmaggia L; Broome M; Woolley J; Bramon E; Howes O; Byrne M; McGuire P
    J Psychiatr Res; 2014 Mar; 50():100-105. PubMed ID: 24398256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.
    Thompson A; Papas A; Bartholomeusz C; Allott K; Amminger GP; Nelson B; Wood S; Yung A
    Schizophr Res; 2012 Nov; 141(2-3):204-9. PubMed ID: 22959742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.